Herpes simplexhttps://en.wikipedia.org/wiki/Herpes_simplex
Herpes simplex est infectio viralis (herpes virus). Infectiones generantur ex parte corporis infecti. Herpes oralis morbus communis est et os vel os implicat. Provenire potest in pustulis parvis in coetibus saepe ulcera dicta vel pusulas febres frigidas. Herpes genitales, saepe simpliciter herpes notae, possunt habere mitia symptomata vel pusulas quae in parvis ulceribus erumpunt et proveniunt. Hae typice sanant per duas ad quattuor septimanas. Fiunt autem medullis dolores antequam pusulae appareant. Pars prima saepe gravior est et coniungi potest cum febre, dolore musculo, nodis lymphis tumentibus et capitis doloribus. Aliae morbositates ab herpes virus includunt: herpetica parola cum digitos, herpes oculi, et herpes neonatales cum novum motum afficit.

Duo genera virus herpes simplex , genus 1 (HSV-1) et typus 2 (HSV-2). HSV-1 communius contagiones circa os causat, dum HSV-2 magis communes infectiones genitales causat. Traduntur directo contactu cum homine infecto. Herpes genitalis indicatur sicut infectio sexualis transmissa. Infanti in partu divulgari potest. Virus post contagionem per nervos sensorios ad corpora cellularum neruorum deferuntur, ubi perpetuam manent. Causae recurrentis includuntur: munus immune diminutum, accentus et nuditas solis.

In pluribus, medicamenta antiviralia tantum sumuntur, cum indicia sunt gravia. Cotidianum antivirale medicamentum alicui praescribi potest, qui crebras contagiones habet. Vaccinum praesto non est et robuste vaccinum simplex herpes non impedit. Curationes cum medicamento antivirali, sicut aciclovir vel valaciclovir, severitatem symptomatis minuere possunt.

Rates mundi vel HSV-1 vel HSV-2 inter 60% et 95% in adultis sunt. HSV-1 in adulescentia infici solet. Aestimatus 536 miliones hominum terrarum (16% incolarum) infecti sunt cum HSV-2 quam 2003 cum maioribus quantitatibus inter mulieres et quae in mundo evolutionis sunt. Plerique cum HSV-2 non cognoscunt quod imbuti sunt.

Curatio OTC Medicamenta
Fugiat aliquem contactum physicum, ut puerum osculatur, dum pusulae adsunt, sicut contactus contagionem aliis hominibus diffundere potest. Absque potu arcu requiescere debes.
#Acyclovir cream
☆ In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
  • Herpes simplex in labro .
  • Herpes simplex ― Herpes simplex in digitis communior est in infantibus quam in adultis.
  • Si symptomata sunt gravia, medicamentum antivirale adhibitum utilissimum est ad symptomata levanda.
  • Si circa os fiat, angular cheilitis distinguantur. Sed in hac tabula verisimilius est herpes esse, quot sunt plures pusulae pusulae circa os.
  • Herpes gingiva ― Infectiones Herpes non solum circa os, sed etiam in locis intraoralibus, perinasalibus et periocularibus accidere possunt.
  • Herpes genitalis in foeminis .
  • Herpes in nates defessus relapsus denotatur.
  • In casibus multae infectionis curationes intensivae requiri possunt, sicut cum herpes zoster.
References Herpes Simplex Type 1 29489260 
NIH
Infectio HSV-1 progreditur per primam infectionem cellularum epithelialium, quam sequitur latency, maxime in neuronibus et reactivatione. HSV-1 plerumque facit eruptiones vesiculares initiales et frequentes, maxime in ore et mucosa genitali. Eius manifestationes ab herpes orolabialibus ad varias condiciones vagantur ut herpetica folliculitis, infectiones cutis, implicatio oculorum et casus graves sicut herpes encephalitis. Therapia antiviralis adiuvat infectio HSV administrare.
Herpes simplex virus type 1 (HSV-1) is a member of the Alphaherpesviridae subfamily. Its structure is composed of linear dsDNA, an icosahedral capsid that is 100 to 110 nm in diameter, with a spikey envelope. In general, the pathogenesis of HSV-1 infection follows a cycle of primary infection of epithelial cells, latency primarily in neurons, and reactivation. HSV-1 is responsible for establishing primary and recurrent vesicular eruptions, primarily in the orolabial and genital mucosa. HSV-1 infection has a wide variety of presentations, including orolabial herpes, herpetic sycosis (HSV folliculitis), herpes gladiatorum, herpetic whitlow, ocular HSV infection, herpes encephalitis, Kaposi varicelliform eruption (eczema herpeticum), and severe or chronic HSV infection. Antiviral therapy limits the course of HSV infection.
 Herpes Simplex Type 2 32119314 
NIH
Herpes simplex virus type 2 (HSV-2) Infectio late diffusa est, circa 22% adultorum annorum 12 et supra afficiens, 45 miliones adultorum in Civitatibus Foederatis. Dum HSV-1 proprie ulcera oris causat, etiam ad laesiones genitales ducere potest. Sed cum aegri vitia genitalia habent, plerumque HSV-2 maxime curae sunt. Signa HSV-2 seditiones saepe vagae sunt, sicut pruritus et pruritus genitalis, quae diagnosin et curationi morari possunt. Haec cunctatio in ulteriore transmissione hominibus non integris evenire potest.
Herpes simplex virus type 2 (HSV-2) continues to be a common infection, affecting approximately 22% of adults ages 12 and older, representing 45 million adults in the United States alone. While HSV-1 often affects the perioral region and can be known to cause genital lesions, HSV-2 is more commonly the consideration when patients present with genital lesions. Despite this, most outbreaks of the infection will present with nonspecific symptoms such as genital itching, irritation, and excoriations, which may cause diagnosis and treatment to be delayed. As a result, further exposure to uninfected individuals may occur.
 Prevention and Treatment of Neonatal Herpes Simplex Virus Infection 32044154 
NIH
Herpes simplex virus (HSV) Infectiones plerumque causant sicut herpes genitales et ulcera frigida in pubescentem et adultorum. Cum HSV infantem in primis 4-6 septimanis vitae inficit, gravi morbo gravissimis consectariis provenire potest. Celeriter diagnosis contagione neonatales HSV crucialus est ad obsistendum morbum de pejus, quominus quaestiones neurologicae (etiam mors) .
Herpes simplex virus (HSV), a member of the Herpesviridae family, is a well-known cause of infections including genital herpes and herpes labialis in the adolescent and adult population. Transmission of HSV infection to an infant during the first 4-6 weeks of life can lead to devastating disease with the potential for poor outcomes. Early diagnosis is imperative when evaluating neonatal HSV infection in order to prevent further disease progression, neurological complications, and even death.
 Herpes simplex virus infection in pregnancy 22566740 
NIH
Herpes simplex Infectio est usitatissima et ex praegnantibus ad infantes eorum transigi potest. Virus hoc gravissimas sanitatis quaestiones vel etiam mortem in fœtibus afferre potest. Dum ipsa in graviditate rara est, saepe in partu fit. Periculum est summum, si mater posterioribus praegnationis gradibus inficiatur. Attamen periculum hoc minui potest utendo medicamentis antiviralibus vel sectionem C-sectioni in quibusdam adiunctis eligendo.
Infection with herpes simplex is one of the most common sexually transmitted infections. Because the infection is common in women of reproductive age it can be contracted and transmitted to the fetus during pregnancy and the newborn. Herpes simplex virus is an important cause of neonatal infection, which can lead to death or long-term disabilities. Rarely in the uterus, it occurs frequently during the transmission delivery. The greatest risk of transmission to the fetus and the newborn occurs in case of an initial maternal infection contracted in the second half of pregnancy. The risk of transmission of maternal-fetal-neonatal herpes simplex can be decreased by performing a treatment with antiviral drugs or resorting to a caesarean section in some specific cases.
 Clinical management of herpes simplex virus infections: past, present, and future 30443341 
NIH
Herpes simplex virus (HSV) Genera 1 et 2 multos per orbem terrarum inficiunt. Fere virus quietum in cellulis nervis post cutem inficit, sed postea reactivate, ulcera frigida causans. Aliquando, gravia problemata, sicut oculi infectiones, inflammationes cerebri, vel condiciones periculosas in fœtibus et hominibus systematis immunis immunis, ducit. Dum medicamenta hodiernae infectiones regere adiuvant, periculum resistentiae medicamentorum et effectus laterum cura manet. Opus novum medicamentis ad virus melius oppugnandum.
Infection with herpes simplex virus (HSV) types 1 and 2 is ubiquitous in the human population. Most commonly, virus replication is limited to the epithelia and establishes latency in enervating sensory neurons, reactivating periodically to produce localized recurrent lesions. However, these viruses can also cause severe disease such as recurrent keratitis leading potentially to blindness, as well as encephalitis, and systemic disease in neonates and immunocompromised patients. Although antiviral therapy has allowed continual and substantial improvement in the management of both primary and recurrent infections, resistance to currently available drugs and long-term toxicity pose a current and future threat that should be addressed through the development of new antiviral compounds directed against new targets.